The ITRI's plan is to adapt existing asthma drugs for transdermal use. "It's still too early to say whether it will be successful or improve on the traditional type," says Wang.
工研院的計畫是要將原有的氣喘藥轉換成為貼劑型，「至於是否會較傳統劑型好，或者會不會成功，現在都言之過早」，他說。